Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients

Coronavirus disease 2019 (COVID-19) caused a progress in research to find a solution to this pandemic. Also, various advances in pharmacotherapy against COVID-19 have emerged. Regarding antiviral therapy, casirivimab and imdevimab are antibodies combination against COVID-19. Standard antiviral thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Hegazy, Sahar K., Tharwat, Samar, Hassan, Ahmed H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426270/
https://www.ncbi.nlm.nih.gov/pubmed/37588660
http://dx.doi.org/10.1515/med-2023-0768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426270/
https://www.ncbi.nlm.nih.gov/pubmed/37588660
http://dx.doi.org/10.1515/med-2023-0768

Ejemplares similares